Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility [0.03%]
高血压治疗中缬沙坦联合疗法的患者视角及其临床价值
David T Nash,Michael S McNamara
David T Nash
The morbidity and mortality benefits of lowering blood pressure (BP) in hypertensive patients are well established, with most individuals requiring multiple agents to achieve BP control. Considering the important role of the renin-angiotens...
Oded Friedman,Alexander G Logan
Oded Friedman
Nocturnal hypertension and non-dipping of blood pressure during sleep are distinct entities that often occur together and are regarded as important harbingers of poor cardiovascular prognosis. This review addresses several aspects related t...
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials [0.03%]
抗高血压药物对颈总动脉中膜厚度影响的meta分析-以血管紧张素Ⅱ受体拮抗剂为中心
Cesare Cuspidi,Francesca Negri,Valentina Giudici et al.
Cesare Cuspidi et al.
Carotid intima-media thickness (IMT) and plaques have been shown to have a strong continuous relationship with cardiovascular (CV) morbidity and mortality; therefore, carotid atherosclerosis, as assessed by ultrasonography, can be regarded ...
Mia Skov-Madsen,My Svensson,Jeppe Hagstrup Christensen
Mia Skov-Madsen
Introduction: Twenty four-hour ambulatory blood pressure monitoring is a clinically validated procedure in evaluation of blood pressure (BP). We hypothesised that the discomfort during cuff inflation would increase the he...
Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study [0.03%]
脂代谢异常对高血压患者心血管风险分层的影响及血脂与其他心血管危险因素之间的关系：来自ICEBERG研究的证据
Giray Kabakci,Nevres Koylan,Baris Ilerigelen et al.
Giray Kabakci et al.
Background: Hypertension, dyslipidemia, and other cardiovascular risk factors are linked epidemiologically, clinically, and metabolically. Intensive/Initial Cardiovascular Examination regarding Blood Pressure levels, Eval...
Hidekatsu Yanai,Kumie Ito,Hiroshi Yoshida et al.
Hidekatsu Yanai et al.
Astaxanthin is a biological antioxidant naturally found in a wide variety of aquatic living organisms, and has shown various pharmacological activities, such as anti-inflammatory and antidiabetic activities. A recent study reported that the...